-
Ruxolitinib
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) Ruxolitinib I-Myelofibrosis Novartis Nge-6 kaJulayi, 2024 -
Crisaborole
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) Crisaborole I-Atopic Dermatitis kunye ne-Eczema Pfizer NgoJuni 11, 2026 -
Relugolix
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) Relugolix Umhlaza weProstatic Takeda kunye no-ASKA NgoJanuwari 24, 2024 -
Vericiguat
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) Vericiguat Ukumelwa yintliziyo Bayer kunye neMSD UCanzibe.24, 2031 -
Abrocitinib
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) Abrocitinib I-Atopic Dermatitis Pfizer NgoFebruwari 11, 2034 -
Rimegepant
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) Rimegepant Intloko yeMigraine I-Biohaven NgoFebruwari 22, 2031 -
Elagolix 834153-87-6
Igama le-API Isalathiso Inkcazo USDMF EU DMF CEP ElagolixI-CAS:834153-87-6 Endometriosis Endlwini -
Relugolix 737789-87-6
Igama le-API Isalathiso Inkcazo USDMF EU DMF CEP Ribociclib CAS: 737789-87-6 I-Antineoplastic Endlwini -
Venetoclax 1257044-40-8
Igama le-API Isalathiso Umqalisi Umhla wokuphelelwa kwePatent(e-US) Venetoclax 1257044-40-8 CLL Abbvie Jun.27,2031 -
I-Velpatasvir(PVP)
Igama le-API Isalathiso Inkcazo USDMF EU DMF CEP I-Velpatasvir(PVP) HCV Endlwini √ -
Thalidomide
Igama le-API Isalathiso Inkcazo USDMF EU DMF CEP Thalidomide Iyeza le-Oncology USP/EP -
Ticagrelor
Igama le-API Isalathiso Inkcazo USDMF EU DMF CEP Ticagrelor I-Anticoagulant Endlwini 28984 √
